Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Jörg Schilcher, Veronika Koeppen, Per Aspenberg & Karl Michaëlsson. (2015) Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthopaedica 86:1, pages 100-107.
Read now
Read now
Jörg Schilcher, Olof Sandberg, Hanna Isaksson & Per Aspenberg. (2014) Histology of 8 atypical femoral fractures. Acta Orthopaedica 85:3, pages 280-286.
Read now
Read now
Jörg Schilcher. (2013) Epidemiology, radiology and histology of atypical femoral fractures. Acta Orthopaedica 84:sup352, pages 1-26.
Read now
Read now
Kristian Bjørgul & Astor Reigstad. (2011) Atypical fracture of the ulna associated with alendronate use. Acta Orthopaedica 82:6, pages 761-763.
Read now
Read now
Ken Lee Puah & Mann Hong Tan. (2011) Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures — a case report. Acta Orthopaedica 82:3, pages 380-382.
Read now
Read now
Kaiya Osugi, Shigeki Miwa, Shinobu Marukawa, Kouhei Marukawa, Yoshiharu Kawaguchi & Shinichi Nakato. (2011) Diaphyseal femoral fatigue fracture associated with bisphosphonate therapy – 3 more cases. Acta Orthopaedica 82:1, pages 112-113.
Read now
Read now
Ioannis Charopoulos, Steve Orme & Peter V Giannoudis. (2011) Fracture risk associated with chronic use of bisphosphonates: evidence today. Expert Opinion on Drug Safety 10:1, pages 67-76.
Read now
Read now
Per Aspenberg, Jörg Schilcher & Anna Fahlgren. (2010) Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Acta Orthopaedica 81:4, pages 460-462.
Read now
Read now
Articles from other publishers (106)
Yannick Rau, Jasper Amtsfeld, Nils Reimers, Ludwig Matrisch, Jasper Frese & Arndt-Peter Schulz. (2023) The development, incidence and treatment trends of trochanteric fractures in Germany: a cohort study. Journal of Orthopaedic Surgery and Research 18:1.
Crossref
Crossref
Kolja M. Thierfelder, Sönke Langner, Thomas Mittlmeier & Marc-André Weber. 2023. Kompendium bildgebende Frakturdiagnostik. Kompendium bildgebende Frakturdiagnostik
85
96
.
Yevgeniya Kushchayeva, Iryna Pestun, Sergiy Kushchayev, Nataliia Radzikhovska & E. Michael Lewiecki. (2022) Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing. Journal of Clinical Medicine 11:24, pages 7477.
Crossref
Crossref
Mathieu Severyns, Dalila Belaid, Kevin Aubert, Ali Bouchoucha, Arnaud Germaneau & Tanguy Vendeuvre. (2022) Biomechanical analysis of the correlation between mid-shaft atypical femoral fracture (AFF) and axial varus deformation. Journal of Orthopaedic Surgery and Research 17:1.
Crossref
Crossref
Mawson Wang, Yu‐Fang Wu & Christian M. Girgis. (2022) Bisphosphonate Drug Holidays: Evidence From Clinical Trials and Real‐World Studies. JBMR Plus 6:6.
Crossref
Crossref
Elena N. Gladkova & Olga M. Lesnyak. (2022) Atypical fracture of the femur in a patient with postmenopausal osteoporosis after four injections of zoledronic acid. Russian Family Doctor 26:1, pages 27-32.
Crossref
Crossref
Elisa Troiano, Tiziano Giacché, Andrea Facchini, Nicholas Crippa Orlandi, Matteo Cacioppo, Marco Saviori, Vanna Bottai, Francesco Muratori, Nicola Mondanelli & Stefano Giannotti. (2022) Surgical and Pharmacological Management of Periprosthetic Atypical Femoral Fractures: A Narrative Literature Review. Geriatric Orthopaedic Surgery & Rehabilitation 13, pages 215145932210903.
Crossref
Crossref
Yasser El Miedany. 2022. New Horizons in Osteoporosis Management. New Horizons in Osteoporosis Management
715
734
.
Branavan Rudran, Jonathan Super, Rajan Jandoo, Victor Babu, Soosai Nathan, Edward Ibrahim & Anatole Vilhelm Wiik. (2021) Current concepts in the management of bisphosphonate associated atypical femoral fractures. World Journal of Orthopedics 12:9, pages 660-671.
Crossref
Crossref
Wei Zhou, Jeroen G. J. van Rooij, Peter R. Ebeling, Annemieke J. M. H. Verkerk & M. Carola Zillikens. (2021) The Genetics of Atypical Femur Fractures—a Systematic Review. Current Osteoporosis Reports 19:2, pages 123-130.
Crossref
Crossref
Debdipta Bose & Nithya J. Gogtay. (2020) Bisphosphonate use and the risk of atypical fractures. Adverse Drug Reaction Bulletin 325:1, pages 1259-1262.
Crossref
Crossref
Kolja M. Thierfelder, Judith S. Gerhardt, Sönke Langner, Thomas Mittlmeier & Marc-André Weber. (2020) Spezielle Aspekte bei StressfrakturenSpecial aspects of stress fractures. Der Radiologe 60:6, pages 506-513.
Crossref
Crossref
Seok-Hyung Won, Soyeon Ahn, Eunjeong Ji, Jung Wee Park, Jin-Kak Kim & Young-Kyun Lee. (2020) Hip and Subtrochanteric or Femoral Shaft Fractures after Bisphosphonate Use in Korean Women, Using Korean National Sample Cohort. Journal of Korean Medical Science 35:25.
Crossref
Crossref
Ifaz T. Haider, Prism S. Schneider & W. Brent Edwards. (2019) The Role of Lower-Limb Geometry in the Pathophysiology of Atypical Femoral Fracture. Current Osteoporosis Reports 17:5, pages 281-290.
Crossref
Crossref
Maria Silvia Spinelli, Eleonora Marini, Primo Andrea Daolio & Andrea Piccioli. (2019) Atypical diaphyseal femoral fractures: Considerations on surgical technique. Injury 50, pages S65-S69.
Crossref
Crossref
Young-Kyun Lee, Dong Won Byun, Sung-Mok Jung, Hye-Young Kwon, Ha-Young Kim, Se Hwa Kim, Tae-Young Kim, Sunmee Jang & Yong-Chan Ha. (2018) Bisphosphonates Use and Risk of Subtrochanteric and Diaphyseal Femur Fractures in Korea: Results from the National Claim Registry. Calcified Tissue International 104:3, pages 313-319.
Crossref
Crossref
Richard A. MarshallJacob C. MandellMichael J. WeaverMarco FerroneAaron SodicksonBharti Khurana. (2018) Imaging Features and Management of Stress, Atypical, and Pathologic Fractures. RadioGraphics 38:7, pages 2173-2192.
Crossref
Crossref
Sonia Vallet, Julia-Marie Filzmoser, Martin Pecherstorfer & Klaus Podar. (2018) Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies. Pharmaceutics 10:4, pages 202.
Crossref
Crossref
Morten Schultz Larsen & Hagen Schmal. (2018) The enigma of atypical femoral fractures. EFORT Open Reviews 3:9, pages 494-500.
Crossref
Crossref
Seung Min RyuDoo Hyung YoonSam-Guk Park. (2018) Atypical Fracture of the Ulna Associated with 3 Years of Bisphosphonate Medication. Journal of the Korean Orthopaedic Association 53:3, pages 277.
Crossref
Crossref
Young-Kyun Lee, Soyeon Ahn, Kyoung Min Kim, Chang Suk Suh & Kyung-Hoi Koo. (2018) Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea. Journal of Korean Medical Science 33:5.
Crossref
Crossref
Beom Seok Lee, Young-Kyun Lee, Heejae Won, Hyungkook Kim & Kyung-Hoi Koo. (2018) Atypical Femoral Fractures: What Do We Know about Them?. Journal of the Korean Fracture Society 31:4, pages 159.
Crossref
Crossref
Seung Hyun LeeYoung Han LeeJin-Suck Suh. (2017) Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users. American Journal of Roentgenology 209:4, pages 867-873.
Crossref
Crossref
Y.-K. Lee, T.-Y. Kim, Y.-C. Ha, S.-H. Song, J. W. Kim, H. C. Shon, J. S. Chang & K.-H. Koo. (2017) Atypical subtrochanteric fractures in Korean hip fracture study. Osteoporosis International 28:10, pages 2853-2858.
Crossref
Crossref
H. P. Bögl, P. Aspenberg & J. Schilcher. (2017) Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series. Osteoporosis International 28:8, pages 2439-2444.
Crossref
Crossref
Ji Wan Kim, Jung Jae Kim, Young-Soo Byun, Oog-Jin Shon, Hyoung Keun Oh, Ki Chul Park, Joon-Woo Kim & Chang-Wug Oh. (2017) Factors affecting fracture location in atypical femoral fractures: A cross-sectional study with 147 patients. Injury 48:7, pages 1570-1574.
Crossref
Crossref
Cemil Kayali, Taskin Altay, Firat Ozan, Serkan Sozkesen & Kamil Yamak. (2017) Atypical femoral shaft fractures secondary to long-term bisphosphonate therapy. Journal of Orthopaedics 14:2, pages 226-230.
Crossref
Crossref
S. P. Mironov, S. S. Rodionova & A. N. Torgashin. (2017) Draft Recommendations. Pharmacotherapy for the Prevention of Repeated Fractures in Patients with Osteoporosis after Surgical Treatment of Pathologic Proximal Femur Fracture. Vestnik travmatologii i ortopedii imeni N.N. Priorova:1, pages 47-57.
Crossref
Crossref
S. P Mironov, S. S Rodionova & A. N Torgashin. (2017) Draft Recommendations. Pharmacotherapy for the Prevention of Repeated Fractures in Patients with Osteoporosis after Surgical Treatment of Pathologic Proximal Femur Fracture. N.N. Priorov Journal of Traumatology and Orthopedics 24:1, pages 47-57.
Crossref
Crossref
Andrew J. Lovy, Diana Patterson, Laura Skeeles, Richard Ghillani, David Joseph, Yangguan Wu & Rohit Hasija. (2017) Atraumatic segmental atypical femur fracture secondary to bisphosphonate use: A case report. Journal of Clinical Orthopaedics and Trauma.
Crossref
Crossref
Lisa N. Miura, Sandhya V. Srikantom & Joseph Schenck. (2017) Double Fixation: Bilateral Bisphosphonate-Related Hip Fractures. The American Journal of Medicine 130:1, pages e13-e15.
Crossref
Crossref
Scott M. Sandilands, Jesus M. Villa & Carlos J. Lavernia. (2016) Bilateral atypical femoral fracture and end-stage arthritis of the hip, treated with total hip arthroplasty. Arthroplasty Today 2:4, pages 147-152.
Crossref
Crossref
Shahin Sheibani-Rad. (2016) Femoral Fractures Following Long-term Bisphosphonate Use. Orthopedics 39:6.
Crossref
Crossref
Yoichi Iizuka, Rumi Takechi, Haku Iizuka, Takuya Omodaka & Kenji Takagishi. (2016) Localized cortical thickening of the femoral diaphysis captured on an X-ray before alendronate therapy in two cases of atypical femoral fracture. Skeletal Radiology 45:10, pages 1403-1407.
Crossref
Crossref
Laura Blum, Karen Cummings, James A. Goulet, Aaron M. Perdue, Cyril Mauffrey & Mark E. Hake. (2016) Atypical femur fractures in patients receiving bisphosphonate therapy: etiology and management. European Journal of Orthopaedic Surgery & Traumatology 26:4, pages 371-377.
Crossref
Crossref
Zeineb Mahjoub, Sonia Jean, Jean-Thomas Leclerc, Jacques P Brown, Dominic Boulet, St?phane Pelet, Charlotte Grondin, Jeannette Dumont, ?tienne L Belzile & Laetitia Michou. (2016) Incidence and Characteristics of Atypical Femoral Fractures: Clinical and Geometrical Data. Journal of Bone and Mineral Research 31:4, pages 767-776.
Crossref
Crossref
Mohammad Kharazmi, Pär Hallberg, Jörg Schilcher, Per Aspenberg & Karl Michaëlsson. (2016) Mortality After Atypical Femoral Fractures: A Cohort Study. Journal of Bone and Mineral Research 31:3, pages 491-497.
Crossref
Crossref
Hanon Sadoni & Hamidreza Arti. (2016) Unusual Foreign Bone Fragment in Femoral Open Fracture. Trauma Monthly 21:1.
Crossref
Crossref
Per Aspenberg. (2016) Atypical fractures, a biased perspective. Injury 47, pages S28-S30.
Crossref
Crossref
. 2016. Diagnostic Imaging: Musculoskeletal Non-Traumatic Disease. Diagnostic Imaging: Musculoskeletal Non-Traumatic Disease
1133
.
Joseph C. Giaconi & C. Travis Watterson. 2016. The Duration and Safety of Osteoporosis Treatment. The Duration and Safety of Osteoporosis Treatment
107
124
.
Takahiro Niikura, Sang Yang Lee, Yoshitada Sakai, Ryosuke Kuroda & Masahiro Kurosaka. (2015) Rare non-traumatic periprosthetic femoral fracture with features of an atypical femoral fracture: a case report. Journal of Medical Case Reports 9:1.
Crossref
Crossref
Claire Acevedo, Hrishikesh Bale, Bernd Gludovatz, Amy Wat, Simon Y. Tang, Mingyue Wang, Björn Busse, Elizabeth A. Zimmermann, Eric Schaible, Matthew R. Allen, David B. Burr & Robert O. Ritchie. (2015) Alendronate treatment alters bone tissues at multiple structural levels in healthy canine cortical bone. Bone 81, pages 352-363.
Crossref
Crossref
Jörg Schilcher, Tet Sen Howe, Meng Ai Png, Per Aspenberg & Joyce SB Koh. (2015) Atypical Fractures Are Mainly Subtrochanteric in Singapore and Diaphyseal in Sweden: A Cross-Sectional Study. Journal of Bone and Mineral Research 30:11, pages 2127-2132.
Crossref
Crossref
Claudia T. Sadro, Claire K. Sandstrom, Nupur Verma & Martin L. Gunn. (2015) Geriatric Trauma: A Radiologist’s Guide to Imaging Trauma Patients Aged 65 Years and Older. RadioGraphics 35:4, pages 1263-1285.
Crossref
Crossref
Yoshitomo Saita, Muneaki Ishijima, Atsuhiko Mogami, Mitsuaki Kubota, Tomonori Baba, Takefumi Kaketa, Masashi Nagao, Yuko Sakamoto, Kensuke Sakai, Yasuhiro Homma, Rui Kato, Nana Nagura, Kei Miyagawa, Tomoki Wada, Lizu Liu, Joe Matsuoka, Osamu Obayashi, Katsuo Shitoto, Masahiko Nozawa, Hajime Kajihara, Hogaku Gen & Kazuo Kaneko. (2014) The incidence of and risk factors for developing atypical femoral fractures in Japan. Journal of Bone and Mineral Metabolism 33:3, pages 311-318.
Crossref
Crossref
Manuel RománAntonio de PradoFederico Rodríguez de Tembleque. (2015) Bilateral Atypical Femoral Fracture in a Man on Long-Term Bisphosphonate and Glucocorticoid Therapy. JBJS Case Connector 5:2, pages e36.
Crossref
Crossref
Joseph R. Geissler, Devendra Bajaj & J. Christopher Fritton. (2015) American Society of Biomechanics Journal of Biomechanics Award 2013: Cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures. Journal of Biomechanics 48:6, pages 883-894.
Crossref
Crossref
Travis Blood, R.J. Feller, Eric Cohen, Christopher T. Born & Roman Hayda. (2015) Atypical Fractures of the Femur: Evaluation and Treatment. JBJS Reviews 3:3.
Crossref
Crossref
Aiman Rifai, Sina Pourtaheri, Andrew Carbone, John J. Callaghan, Chris M. Stadler, Nicole Record & Kimona Issa. (2015) Bilateral Femur Fractures Associated With Short-term Bisphosphonate Use. Orthopedics 38:2.
Crossref
Crossref
Hyo-Sang Kim, Han Young Jung, Myeong-Ok Kim, Kyung-Lim Joa, Yeo Ju Kim, Su-Yeon Kwon & Chang-Hwan Kim. (2015) Successful Conservative Treatment. Medicine 94:5, pages e446.
Crossref
Crossref
S. H. S. Tan, S. Saseendar, B. H. M. Tan, A. Pawaskar & V. P. Kumar. (2014) Ulnar fractures with bisphosphonate therapy: a systematic review of published case reports. Osteoporosis International 26:2, pages 421-429.
Crossref
Crossref
Efstathios G. Ballas, Andreas F. Mavrogenis, Eirineos Karamanis, Zinon T. Kokkalis, Evanthia Mitsiokapa, Demetrios Koulalis, Demetrios Mastrokalos & Panayiotis J. Papagelopoulos. (2014) Low-energy femoral shaft fractures after long-term alendronate therapy: report of seven cases. European Journal of Orthopaedic Surgery & Traumatology 25:1, pages 181-187.
Crossref
Crossref
Marc S. Haro, Julia R. Bruene, Kathleen Weber & Bernard R. BachJrJr. 2015. Stress Fractures in Athletes. Stress Fractures in Athletes
111
124
.
Myung-Sang Moon, Ki-Tae Kwon, Chang-Won Ha, Sung-Soo Kim, Sung Sim Kim & Hanlim Moon. (2015) BONE HISTOLOGY OF PATIENTS WITH ALENDRONATE-MEDIATED FRACTURED BONE — A NEW ENTITY OF ATYPICAL OSTEOMALACIA. Journal of Musculoskeletal Research 17:03, pages 1450011.
Crossref
Crossref
Thomas A. Einhorn, Yelena Bogdan & Paul Tornetta. (2014) Bisphosphonate-Associated Fractures of the Femur. Journal of Orthopaedic Trauma 28:7, pages 433-438.
Crossref
Crossref
Matthew A. Varacallo & Ed J. Fox. (2014) Osteoporosis and Its Complications. Medical Clinics of North America 98:4, pages 817-831.
Crossref
Crossref
Per Aspenberg & Jörg Schilcher. (2014) Atypical Femoral Fractures, Bisphosphonates, and Mechanical Stress. Current Osteoporosis Reports 12:2, pages 189-193.
Crossref
Crossref
Joseph Borrelli, Joseph Lane, Susan Bukata, Kenneth A. Egol, Richelle Takemoto, Gerard Slobogean & Saam Morshed. (2014) Atypical Femur Fractures. Journal of Orthopaedic Trauma 28:Supplement 1, pages S36-S42.
Crossref
Crossref
Christina J. Gutowski & Asif M. Ilyas. (2014) Evaluation and Medical Management of Fragility Fractures of the Upper Extremity. Orthopedic Clinics of North America 45:2, pages 233-243.
Crossref
Crossref
Fuat Bilgili, Sami Sökücü, Ayhan Kılıç, Atilla Sancar Parmaksızoğlu, Özgür Mengeş & Yavuz Selim Kabukçuoğlu. (2013) Low-energy femoral stress fracture in long-term bisphosphonate use: conservative and surgical treatment. European Orthopaedics and Traumatology 5:1, pages 15-23.
Crossref
Crossref
Sune Larsson & Nicola L. Fazzalari. (2012) Anti-osteoporosis therapy and fracture healing. Archives of Orthopaedic and Trauma Surgery 134:2, pages 291-297.
Crossref
Crossref
Karl-Göran Thorngren. 2014. European Surgical Orthopaedics and Traumatology. European Surgical Orthopaedics and Traumatology
281
300
.
Elizabeth Shane, David Burr, Bo Abrahamsen, Robert A Adler, Thomas D Brown, Angela M Cheung, Felicia Cosman, Jeffrey R Curtis, Richard Dell, David W Dempster, Peter R Ebeling, Thomas A Einhorn, Harry K Genant, Piet Geusens, Klaus Klaushofer, Joseph M Lane, Fergus McKiernan, Ross McKinney, Alvin Ng, Jeri Nieves, Regis O'Keefe, Socrates Papapoulos, Tet Sen Howe, Marjolein CH van der Meulen, Robert S Weinstein & Michael P Whyte. (2014) Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research. Journal of Bone and Mineral Research 29:1, pages 1-23.
Crossref
Crossref
MICHAEL MCCLUNG. (2013) Controversies in Osteoporosis Management. Clinical Obstetrics and Gynecology 56:4, pages 743-748.
Crossref
Crossref
Raúl Parrón Cambero, Antonio Rey López, Félix Tomé-Bermejo & Roberto Cibantos Martínez. (2012) Atypical bilateral femoral shaft fracture in patient treated with bisphosphonates. European Journal of Orthopaedic Surgery & Traumatology 23:S2, pages 219-223.
Crossref
Crossref
Majid Yazdani & John J. Wixted. (2013) Hip Fracture. Hospital Medicine Clinics 2:4, pages e552-e560.
Crossref
Crossref
Pingal A. Desai, Parth A. Vyas & Joseph M. Lane. (2013) Atypical Femoral fractures: A Review of the Literature. Current Osteoporosis Reports 11:3, pages 179-187.
Crossref
Crossref
Inari S. Tamminen, Tero Yli-Kyyny, Hanna Isaksson, Mikael J. Turunen, Xiaoyu Tong, Jukka S. Jurvelin & Heikki Kröger. (2013) Incidence and bone biopsy findings of atypical femoral fractures. Journal of Bone and Mineral Metabolism 31:5, pages 585-594.
Crossref
Crossref
M.B. Allison, L. Markman, Z. Rosenberg, R.L. Vieira, J. Babb, N. Tejwani & V. Peck. (2013) RETRACTED: Atypical incomplete femoral fractures in asymptomatic patients on long term bisphosphonate therapy. Bone 55:1, pages 113-118.
Crossref
Crossref
G. S. Golubev. (2013) ATYPICAL FRACTURES DUE TO LONG TREATMENT WITH BISPHOSPHONATES (CRITICAL REVIEW). Traumatology and Orthopedics of Russia 19:1, pages 113-123.
Crossref
Crossref
Yerl-Bo SungJung-Yun ChoiKyu-Sub Um. (2013) Bisphosphonate Related Atypical Femoral Fracture. Hip & Pelvis 25:1, pages 66.
Crossref
Crossref
Michael McClung, Steven T. Harris, Paul D. Miller, Douglas C. Bauer, K. Shawn Davison, Larry Dian, David A. Hanley, David L. Kendler, Chui Kin Yuen & E. Michael Lewiecki. (2013) Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday. The American Journal of Medicine 126:1, pages 13-20.
Crossref
Crossref
Roberto C Güerri-Fernández, Xavier Nogués, José M Quesada Gómez, Elisa Torres del Pliego, Lluís Puig, Natalia García-Giralt, Guy Yoskovitz, Leonardo Mellibovsky, Paul K Hansma & Adolfo Díez-Pérez. (2013) Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls. Journal of Bone and Mineral Research 28:1, pages 162-168.
Crossref
Crossref
Y. Açil, B. Möller, P. Niehoff, K. Rachko, V. Gassling, J. Wiltfang & M.J.K. Simon. (2012) The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells. Journal of Cranio-Maxillofacial Surgery 40:8, pages e229-e235.
Crossref
Crossref
Andreas Seraphim, Nawfal Al-Hadithy, Simon C. Mordecai & Shafic Al-Nammari. (2012) Do bisphosphonates cause femoral insufficiency fractures?. Journal of Orthopaedics and Traumatology 13:4, pages 171-177.
Crossref
Crossref
Stephanie T. Chang, Adam S. Tenforde, Christopher D. Grimsrud, Felice S. O'Ryan, Joel R. Gonzalez, David M. Baer, Malini Chandra & Joan C. Lo. (2012) Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy. Bone 51:3, pages 524-527.
Crossref
Crossref
Satoshi Sasaki, Naohisa Miyakoshi, Michio Hongo, Yuji Kasukawa & Yoichi Shimada. (2012) Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series. Journal of Bone and Mineral Metabolism 30:5, pages 561-567.
Crossref
Crossref
Fahad Alshahrani & David Kendler. (2012) Femoral Fractures in Osteoporotic Patients on Bisphosphnates. A Case Report. Journal of Clinical Densitometry 15:3, pages 380-384.
Crossref
Crossref
Mary K. Grady, J. Tracy Watson & Lisa K. Cannada. (2012) Treatment of Femoral Fracture Nonunion After Long-term Bisphosphonate Use. Orthopedics 35:6.
Crossref
Crossref
Ricardo César Restrepo, Francisco Vargas Grajales, Oscar Jaír Felipe-Díaz, Carlos Jaime Velásquez Franco, Aura Ligia Zapata-Castellanos & Jaime Alberto Valencia. (2012) Fractura patológica atribuible a la terapia con bisfosfonatos. Revista Colombiana de Reumatología 19:2, pages 92-98.
Crossref
Crossref
Renata La Rocca VieiraZehava Sadka RosenbergMary B. AllisonShelly A. ImJames BabbValerie Peck. (2012) Frequency of Incomplete Atypical Femoral Fractures in Asymptomatic Patients on Long-Term Bisphosphonate Therapy. American Journal of Roentgenology 198:5, pages 1144-1151.
Crossref
Crossref
R. N. ThompsonJ. R. A. PhillipsS. H. J. McCauleyJ. R. M. ElliottC. G. Moran. (2012) Atypical femoral fractures and bisphosphonate treatment. The Journal of Bone and Joint Surgery. British volume 94-B:3, pages 385-390.
Crossref
Crossref
N. Nicolaou, Y. Agrawal, M. Padman, J. A. Fernandes & M. J. Bell. (2012) Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates. Journal of Children's Orthopaedics 6:1, pages 21-27.
Crossref
Crossref
Frieda Feldman. (2011) Atypical diaphyseal femoral fractures—new aspects. Skeletal Radiology 41:1, pages 75-81.
Crossref
Crossref
Rita Wickham. (2011) Osteoporosis Related to Disease or Therapy in Patients With Cancer. Clinical Journal of Oncology Nursing 15:6, pages E90-E104.
Crossref
Crossref
Rami El Rachkidi, Marie-Laure Sari-Leret & Stephane Wolff. (2011) Atypical Bilateral Pedicle Fracture in Long-Term Bisphosphonate Therapy. Spine 36:26, pages E1769-E1773.
Crossref
Crossref
Maurice Audran, Bernard Cortet & Thierry Thomas. (2011) What do we know about atypical femoral fractures? Insights and enigmas. Joint Bone Spine 78:6, pages 568-571.
Crossref
Crossref
L.J. Kidd, N.R. Cowling, A.C.K. Wu, W.L. Kelly & M.R. Forwood. (2011) Bisphosphonate treatment delays stress fracture remodeling in the rat ulna. Journal of Orthopaedic Research 29:12, pages 1827-1833.
Crossref
Crossref
Zehava Sadka RosenbergRenata La Rocca VieiraSarah S. ChanJames BabbYakup AkyolLeon D. RybakSandra MooreJenny T. BencardinoValerie PeckNirmal C. TejwaniKenneth A. Egol. (2011) Bisphosphonate-Related Complete Atypical Subtrochanteric Femoral Fractures: Diagnostic Utility of Radiography. American Journal of Roentgenology 197:4, pages 954-960.
Crossref
Crossref
Maurice Audran, Bernard Cortet & Thierry Thomas. (2011) Que sait-on des fractures fémorales atypiques ? Entre progrès et inconnues. Revue du Rhumatisme 78:5, pages 423-426.
Crossref
Crossref
Andrew J. Laster & S. Bobo Tanner. (2011) Duration of Treatment in Postmenopausal Osteoporosis: How Long to Treat and What are the Consequences of Cessation of Treatment?. Rheumatic Disease Clinics of North America 37:3, pages 323-336.
Crossref
Crossref
Mark E. Puhaindran, Azeez Farooki, Matthew R. Steensma, Meera Hameed, John H. Healey & Patrick J. Boland. (2011) Atypical Subtrochanteric Femoral Fractures in Patients with Skeletal Malignant Involvement Treated with Intravenous Bisphosphonates. Journal of Bone and Joint Surgery 93:13, pages 1235-1242.
Crossref
Crossref
Michael Pazianas & Bo Abrahamsen. (2011) Safety of bisphosphonates. Bone 49:1, pages 103-110.
Crossref
Crossref
Mikko T. Ovaska, Tatu J. Mäkinen & Rami Madanat. (2011) Simultaneous bilateral subtrochanteric fractures following risedronate therapy. Journal of Orthopaedic Science 16:4, pages 467-470.
Crossref
Crossref
Jörg Schilcher, Karl Michaëlsson & Per Aspenberg. (2011) Bisphosphonate Use and Atypical Fractures of the Femoral Shaft. New England Journal of Medicine 364:18, pages 1728-1737.
Crossref
Crossref
Andrea Giusti, Neveen A.T. Hamdy, Olaf M. Dekkers, Sharita R. Ramautar, Sander Dijkstra & Socrates E. Papapoulos. (2011) Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features. Bone 48:5, pages 966-971.
Crossref
Crossref
Seo Young Kim, Sebastian Schneeweiss, Jeffrey N Katz, Raisa Levin & Daniel H Solomon. (2011) Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. Journal of Bone and Mineral Research 26:5, pages 993-1001.
Crossref
Crossref
Chandravathi Loke, Wilson C. Mertens, Michael J. Yunes, Rebecca A. Levy & Grace Makari-Judson. (2011) Association of spontaneous bilateral femoral stress fractures with zoledronic acid use in a patient with metastatic breast cancer—a cautionary tale. Community Oncology 8:3, pages 137-140.
Crossref
Crossref
R. Rizzoli, K. Åkesson, M. Bouxsein, J. A. Kanis, N. Napoli, S. Papapoulos, J.-Y. Reginster & C. Cooper. (2010) Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporosis International 22:2, pages 373-390.
Crossref
Crossref
Tero Yli-Kyyny. (2011) Bisphosphonates and Atypical Fractures of Femur. Journal of Osteoporosis 2011, pages 1-5.
Crossref
Crossref
Elizabeth Shane, David Burr, Peter R Ebeling, Bo Abrahamsen, Robert A Adler, Thomas D Brown, Angela M Cheung, Felicia Cosman, Jeffrey R Curtis, Richard Dell, David Dempster, Thomas A Einhorn, Harry K Genant, Piet Geusens, Klaus Klaushofer, Kenneth Koval, Joseph M Lane, Fergus McKiernan, Ross McKinney, Alvin Ng, Jeri Nieves, Regis O'Keefe, Socrates Papapoulos, Howe Tet Sen, Marjolein CH van der Meulen, Robert S Weinstein & Michael Whyte. (2010) Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research. Journal of Bone and Mineral Research 25:11, pages 2267-2294.
Crossref
Crossref
Lee F. RogersMihra Taljanovic. (2010) FDA Statement on Relationship Between Bisphosphonate Use and Atypical Subtrochanteric and Femoral Shaft Fractures: A Considered Opinion. American Journal of Roentgenology 195:3, pages 563-566.
Crossref
Crossref
Andrea Giusti, Neveen A.T. Hamdy & Socrates E. Papapoulos. (2010) Atypical fractures of the femur and bisphosphonate therapy. Bone 47:2, pages 169-180.
Crossref
Crossref
Bo Abrahamsen. (2010) Adverse Effects of Bisphosphonates. Calcified Tissue International 86:6, pages 421-435.
Crossref
Crossref
Jack A. PorrinoJr.Jr., Chad A. Kohl, Mihra Taljanovic & Lee F. Rogers. (2010) Diagnosis of Proximal Femoral Insufficiency Fractures in Patients Receiving Bisphosphonate Therapy. American Journal of Roentgenology 194:4, pages 1061-1064.
Crossref
Crossref